Changes in physio-biochemical status of cut of roses under fungal elicitor to control gray mold

The control of disease and improvement of flower quality is mainly influenced by natural and chemical compounds. Elicitors are pathogen signal metabolites, while methyl jasmonate (MeJA) and brassinosteroids (BRs) are plant growth regulators, which significantly activate defense mechanisms in plants and maintain the quality of cut flowers.

This study aimed to evaluate the effects of BR (1 and 2 µM), MeJA (0.1 and 0.2 Mm), and fungal elicitor (FE, 600, 800, and 1000 mg l⁻¹) as pulsing method, alone and in combination with spraying of Botrytis cinerea (BC). The physiological traits and inhibition effect on fungal growth on cut rose flowers. The results showed that 1000 and 800 mg l⁻¹ of FE were the most effective treatments to improve the carbohydrate content, relative water content (RWC), antioxidant activities, and vase life of rose flowers.

In addition to these treatments, 0.1 and 0.2 mM MeJA and 1 µM BR significantly improved the quality of cut rose flowers. The best inhibitors of gray mold disease were all levels of FE followed by 0.2 mM MeJA and 1 µM BR. Superoxide dismutase and catalase activities continuously increased over time. Heat map (HM) analysis showed catalase and vase life were the most effective traits in determining changes in the physiological status of cut rose flowers. The study suggests the use of elicitors, particularly 1000 mg l⁻¹ FE to obtain flowers with a long vase life.

Read the complete research at

Naeemi, Mansoreh & Jari, Sepideh & Zarrinnia, Vahid & Fatehi, Foad. (2022). Changes in physio-biochemical status of cut of rose (Rosa Hybrida L. cv. Samurai) flowers under methyl Jasmonate, brassinosteroid, and fungal elicitor to control gray mold. Scientia Horticulturae. 306. 111402. 10.1016/j.scienta.2022.111402. 

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.